TB Alliance Portfolio
March 2010

Moxifloxacin
PA-824
TMC 207
Nitroimidazoles
Mycobacterial Gyrase Inhibitors
Riminophenazines
InhA Inhibitors
New Generation Diarylquinoline
Bi-functional Molecules
Phenotypic Screening
Tryptanthrins
LeuRS Inhibitors
GSK Whole-Cell Screening
Malate Synthase Inhibitors
Energy Metabolism Inhibitors
RNA Polymerase Inhibitors
Natural Products
Menaquinone Biosynthesis Inhibitors
Protease Inhibitors
Topoisomerase I Inhibitors
NITD Portfolio